Skip to main content

Table 5 Parameters of DCE-MRI according to pathologic biomarkers

From: US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers

  

Ktrans

kep

SER

(1/min)

(1/min)

  

Mean

p

Mean

p

Mean

p

Overall

       

Tumor size

<2 cm (n = 20)

0.134

0.885

0.495

0.440

1.118

0.471

≥2 cm (n = 17)

0.131

 

0.468

 

1.085

 

HG

Low (n = 16)

0.136

0.829

0.484

0.965

1.136

0.199

High (n = 21)

0.131

 

0.481

 

1.077

 

ER

Neg (n = 15)

0.156

0.124

0.513

0.337

1.111

0.746

Pos (n = 22)

0.118

 

0.462

 

1.096

 

PR

Neg (n = 13)

0.154

0.162

0.485

0.932

1.119

0.613

Pos (n = 24)

0.122

 

0.481

 

1.091

 

HER-2

Neg (n = 31)

0.138

0.051

0.487

0.684

1.109

0.526

Pos (n = 6)

0.107

 

0.458

 

1.069

 

TNBC

Neg (n = 27)

0.116

0.048

0.482

0.985

1.103

0.996

Pos (n = 10)

0.178

 

0.483

 

1.103

 

Ki-67

Low (n = 18)

0.113

0.060

0.470

0.629

1.103

0.989

High (n = 19)

0.154

 

0.495

 

1.102

 

LVI

Neg (n = 23)

0.135

0.514

0.504

0.818

1.115

0.726

Pos (n = 3)

0.113

 

0.478

 

1.082

 

LN mets

Neg (n = 24)

0.123

0.206

0.498

0.412

1.112

0.581

Pos (n = 13)

0.152

 

0.453

 

1.085

Â